Principal Investigators - Professor Mosepele Mosepele MD, MSc | Tendani Gaolathe BS, MD | Kathleen Wirth Hurwitz
- To develop a set of implementation strategies for integrated HIV-CVD care within an existing HIV care platform for adults with HIV and hypertension,
- To conduct a pilot test to explore implementation outcomes using the RE-AIM framework to inform adaptation for broader testing,
- To measure the implementation outcomes of a multi-component strategy in improving EBI uptake and improvement success rates in the HTN cascade among adults with a dual diagnosis of HIV and Hypertension.
Study Design: Cluster randomised trial
Study Population & Size: Pilot: 300 adults with HIV and hypertension in 2 IDC clinics (objective 2);
Cluster randomised trial: 3000 adults with HIV and hypertension in 10 IDC clinics (objective 3)
Study Duration: 01/09/2020 to 31/08/2025
Sponsor: National Institutes of Health/ The National Heart, Lung, and Blood Institute (NIH/NHLBI).